Analysis of the antibody structure based on high-resolution crystallographic studies

New Biotechnology

Volumn 28, Issue 5, 2011, Pages 435-447

  Narciso, Jo Erika T ^a   Uy, Iris Diana C ^a   Cabang, April B ^a   Chavez, Jenina Faye C ^a   Pablo, Juan Lorenzo B ^a   Padilla Concepcion, Gisela P ^a   Padlan, Eduardo A ^a  

^a University of the Philippines Diliman ^*  (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY MOLECULES; ANTIBODY STRUCTURES; COMPLEMENTARITY-DETERMINING REGIONS; CRYSTALLOGRAPHIC STUDIES; HIGH RESOLUTION; HIGH-RESOLUTION STRUCTURES; SOLVENT ACCESSIBILITY; STRUCTURAL INFORMATION; VARIABLE DOMAIN;

ANTIBODIES;

CYTOCHROME; INTERLEUKIN 18; LIGAND; LYSOZYME; RIBONUCLEASE; SOLVENT;

ANTIBODY ENGINEERING; ANTIBODY STRUCTURE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; COMPLEMENTARITY DETERMINING REGION; CRYSTALLOGRAPHY; HUMAN; MOLECULE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; WASTE;

ANIMALS; ANTIBODIES; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN ENGINEERING;

EID: 80052809964     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2011.03.012     Document Type: Review

References (37)

1. Poljak R.J., et al. Three-Dimensional Structure of the Fab' Fragment of a Human Immunoglobulin at 2.8-Å Resolution. Proc. Natl. Acad. Sci. USA. 1973, 70:3305-3310.
2. Wu T.T., Kabat E.A. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 1970, 132:211-250.
3. Berman H.M., et al. The Protein Data Bank. Nucl. Acids Res. 2000, 28:235-242.
4. Bhat T.N., et al. Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding. Nature 1990, 347:483-485.
5. Matsumiya S., et al. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J. Mol. Biol. 2007, 368:767-779.
6. Foote J., Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 1992, 224:487-499.
7. Jones P.T., et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 1986, 321:522-525.
8. Queen C., et al. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA 1989, 86:10029-10033.
9. Verhoeyen M., et al. Reshaping human antibodies: grafting an antilysozyme activity. Science 1988, 239:1534-1536.
10. Padlan E.A. A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties. Mol. Immunol. 1991, 28:489-498.
11. Roguska M.A., et al. Humanization of murine monoclonal antibodies through variable domain resurfacing. Proc. Natl. Acad. Sci. USA 1994, 91:969-973.
12. Padlan E.A., et al. Identification of specificity-determining residues in antibodies. FASEB J. 1995, 9:133-139.
13. Connolly M.L. Analytical molecular surface calculation. J. Appl. Crystallogr. 1983, 16:548-558.
14. Cohen G.H., et al. Water molecules in the antibody-antigen interface of the structure of the Fab HyHEL-5-lysozyme complex at 1.7 Å resolution: comparison with results from isothermal titration calorimetry. Acta. Crystallogr. D. Biol. Crystallogr. 2005, 61:628-633.
15. Argiriadi M.A., et al. Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18. J. Biol. Chem. 2009, 284:24478-24489.
16. Stanfield R., et al. Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs. Structure 1999, 7:131-142.
17. Zhu X., et al. Structural basis for antibody catalysis of a cationic cyclization reaction. J. Mol. Biol. 2003, 329:69-83.
18. Fotinou C., et al. Structure of an Fab fragment against a C-terminal peptide of hCG at 2.0Å resolution. J. Biol. Chem. 1998, 273:22515-22518.
19. Beyer B.M., et al. Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody. J. Mol. Biol. 2008, 382:942-955.
20. Zhou T., et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 2007, 445:732-737.
21. Staelens S., et al. Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain. J. Biol. Chem. 2006, 281:2225-2231.
22. Acchione M., et al. Light chain somatic mutations change thermodynamics of binding and water coordination in the HyHEL-10 family of antibodies. Mol. Immunol. 2009, 47:457-464.
23. Mylvaganam S.E., et al. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution. J. Mol. Biol. 1998, 281:301-322.
24. Zhu X., et al. Complete reaction cycle of a cocaine catalytic antibody at atomic resolution. Structure 2006, 14:205-216.
25. Decanniere K., et al. Degenerate interfaces in antigen-antibody complexes. J. Mol. Biol. 2001, 313:473-478.
26. Koide A., et al. Exploring the capacity of minimalist protein interfaces: interface energetics and affinity maturation to picomolar KD of a single-domain antibody with a flat paratope. J. Mol. Biol. 2007, 373:941-953.
27. Desmyter A., et al. Three camelid VHH domains in complex with porcine pancreatic α-amylase. J. Biol. Chem. 2002, 277:23645-23650.
28. Dumoulin M., et al. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 2003, 424:783-788.
29. Stanfield R.L., et al. Crystal structure of a shark single-domain antibody V region in complex with lysozyme. Science 2004, 305:1770-1773.
30. Stanfield R.L., et al. Maturation of shark single-domain (IgNAR) antibodies: evidence for induced-fit binding. J. Mol. Biol. 2007, 367:358-372.
31. Padlan E.A. Anatomy of the antibody molecule. Mol. Immunol. 1994, 31:169-217.
32. Harris L.J., et al. Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 1997, 36:1581-1597.
33. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 1997, 18:2714-2723.
34. Padlan E.A. On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands. PROTEINS: Struc. Funct. Genet. 1990, 7:112-124.
35. Kabat E.A., et al. Sequences of Proteins of Immunological Interest 1991, US Department of Health and Human Services, Public Health Service, National Institutes of Health (NIH Publication No. 91-3242). 5th ed.
36. Desmyter A., et al. Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody. J. Biol. Chem. 2001, 276:26285-26290.
37. Dooley H., et al. First molecular and biochemical analysis of in vivo affinity maturation in an ectothermic vertebrate. Proc. Natl. Acad. Sci. USA 2006, 103:1846-1851.